SEVERAL recent studies have shown that hyperthermia is able to enhance the direct cytotoxic effect of misonidazole (Bleehen et al., 1978; Hall et al., 1977; Stratford & Adams, 1977; Stone, 1978) . These observations led us to investigate the interaction between radiation, hyperthermia and misonidazole (MIS) in an attempt to evaluate the role of such multimodality treatment in experimental tumours. During these experiments we observed an increase in the acute toxicity to mice when heated locally in the presence of MIS. Such a reaction has not previously been described, but as it may have implications for further work in that field, we find it of importance to report here.
The increased toxicity was initially observed in mice treated with MIS and local hyperthermia (43-5°C). In this experiment, 14/37 mice died within 2 days of treatment with 0 5 mg/g MIS, injected i.p., 30 min before local hyperthermia was applied to the tumour-bearing leg. Since this was a considerably higher lethality rate than was expected, further toxicological studies were initiated.
Ten to twelve-weeks old male and female C3H/Aa mice bred in our own colony were used for LD5o/30d assays. centration is found about 30 min after i.p. administration, followed by a rapid elimination with a half-value time of about 1-5h (Fowler et al., 1976) . The increased death rate may be due to an influence of the drug on temperature regulation. Animals heated with the described technique normally show an increase in body temperature from 36°C to about 38 5°C during a 1 h treatment. This temperature rise occurs mainly within the first 20 min of the heating, and then plateaus. In mice given MIS together with local hyperthermia, the temperature increase was greater, and occurred over the entire treatment period, reaching an average temperature close to 41°C (Fig. 2) . Thus, MIS seemed to influence the temperature regulation in mice given a local hyperthermic treatment.
The increase in temperature apparently causes the mice to become weak, with intense sweat production; and several drug-treated mice died at the end of the treatment.
The abnormal increase in body temperature was largely independent of the MIS dose, and no difference was observed with doses between 0 5 and 2-0 mg/g body weight. However, mice receiving a dose of 0-25 mg/g tolerated the treatment better. Toxic doses of nitroimidazoles are known to cause abnormalities in the temperature regulation in experimental animals (unpublished information from drug companies). This is normally expressed as hypothermia in animals kept at room temperature. However, if part of the animal is heated or otherwise exposed to an elevated temperature, the disorder in temperature regulation may result in systemic hyperthermia and death.
The observation that only a simultaneous treatment resulted in increased toxicity may be related to the rapid absorption and elimination of MIS known to occur in mice. If a similar hyperthermic enhancement of acute toxicity occurs in man, it is likely to be over a greater interval between drug application and heating, due to the slower elimination of MIS in humans (Fowler et at., 1976) .
The combined use of MIS and hyperthermia has been suggested as a potential therapy of human tumours (Bleehen et al., 1978; Johnson, 1978) . However, in order to avoid unexpected side effects, one may urge caution with such regimens until further toxicological studies on the interaction between hyperthermia and MIS have been made.
